Stifel Financial’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
Other funds holding SWTX
GCL
TAL
HI
BCM
MF
Stifel Financial's SWTX Position: Q2 2025 in Review
Stifel Financial sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 25,102 shares — an estimated $1.11M sold.
Stifel Financial first reported a position in SWTX in Q4 2020 and held it in 18 quarters. The position peaked at $1.11M in Q1 2025. 223 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.
- Stifel Financial reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
- Stifel Financial sold 25,102 SpringWorks Therapeutics shares in Q2 2025, an estimated $1.11M.
- Stifel Financial first reported a position in SpringWorks Therapeutics in Q4 2020 and held it in 18 quarters.
- Stifel Financial's SpringWorks Therapeutics position peaked at $1.11M in Q1 2025.
- 223 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.
Based on Stifel Financial's 13F filing for Q2 2025, filed 14 Aug 2025.